n(g),n(g')-dimethyl-l-arginine has been researched along with Schizophrenia in 7 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Plasma ADMA and the L-arginine:ADMA ratio did not differ between schizophrenia patients and controls." | 7.81 | Asymmetric dimethylarginine in somatically healthy schizophrenia patients treated with atypical antipsychotics: a case-control study. ( Fink-Jensen, A; Jorgensen, A; Jorgensen, MB; Knorr, U; Lykkesfeldt, J; Olsen, NV; Poulsen, HE; Soendergaard, MG; Staalsø, JM, 2015) |
| "Serum concentrations of asymmetric dimethylarginine (ADMA) in patients with schizophrenia, schizoaffective disorder, bipolar disorder, and depression were determined and compared to serum concentrations in healthy individuals." | 4.02 | Asymmetric dimethylarginine in psychiatric disorders. ( Braun, D; Haen, E; Schlossmann, J, 2021) |
| "Plasma ADMA and the L-arginine:ADMA ratio did not differ between schizophrenia patients and controls." | 3.81 | Asymmetric dimethylarginine in somatically healthy schizophrenia patients treated with atypical antipsychotics: a case-control study. ( Fink-Jensen, A; Jorgensen, A; Jorgensen, MB; Knorr, U; Lykkesfeldt, J; Olsen, NV; Poulsen, HE; Soendergaard, MG; Staalsø, JM, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Braun, D | 1 |
| Schlossmann, J | 1 |
| Haen, E | 1 |
| Zincir, S | 2 |
| Zincir, SB | 1 |
| Doruk, A | 1 |
| Erdem, M | 1 |
| Celik, C | 2 |
| Ak, M | 1 |
| Garip, B | 1 |
| Yükselir, C | 1 |
| Karaahmetoğlu, B | 1 |
| Jorgensen, A | 1 |
| Knorr, U | 1 |
| Soendergaard, MG | 1 |
| Lykkesfeldt, J | 1 |
| Fink-Jensen, A | 1 |
| Poulsen, HE | 1 |
| Jorgensen, MB | 1 |
| Olsen, NV | 1 |
| Staalsø, JM | 1 |
| Nonaka-Hashida, S | 1 |
| Sekine, M | 1 |
| Ozeki, Y | 1 |
| Fujii, K | 1 |
| Akiyama, K | 1 |
| Shimoda, K | 1 |
| Tsunoda, M | 1 |
| Katane, M | 1 |
| Saitoh, Y | 1 |
| Miyamoto, T | 1 |
| Homma, H | 1 |
| Maia-de-Oliveira, JP | 1 |
| Kandratavicius, L | 1 |
| Nunes, EA | 1 |
| Machado-de-Sousa, JP | 1 |
| Hallak, JE | 1 |
| Dursun, SM | 1 |
| Yang, YJ | 1 |
| Xiong, JW | 1 |
| Zhao, Y | 1 |
| Zhan, JQ | 1 |
| Chen, HB | 1 |
| Yan, K | 1 |
| Hu, MR | 1 |
| Yu, B | 1 |
| Wei, B | 1 |
| Cayci, T | 1 |
| Ozdemir, B | 1 |
| Akgul, EO | 1 |
| Balikci, A | 1 |
| Uzun, O | 1 |
| Yaman, H | 1 |
1 review available for n(g),n(g')-dimethyl-l-arginine and Schizophrenia
| Article | Year |
|---|---|
Nitric Oxide's Involvement in the Spectrum of Psychotic Disorders.
Topics: Antipsychotic Agents; Arginine; Brain; Clinical Trials as Topic; Humans; Nitric Oxide; Nitric Oxide | 2016 |
6 other studies available for n(g),n(g')-dimethyl-l-arginine and Schizophrenia
| Article | Year |
|---|---|
Asymmetric dimethylarginine in psychiatric disorders.
Topics: Arginine; Bipolar Disorder; Female; Humans; Male; Psychotic Disorders; Schizophrenia | 2021 |
Asymmetric dimethylarginine (ADMA) and treatment response relationship in male patients with first-episode schizophrenia: a controlled study.
Topics: Adult; Antipsychotic Agents; Arginine; Humans; Male; Middle Aged; Nitric Oxide; Schizophrenia; Treat | 2014 |
Asymmetric dimethylarginine in somatically healthy schizophrenia patients treated with atypical antipsychotics: a case-control study.
Topics: Adult; Antipsychotic Agents; Arginine; Biomarkers; Case-Control Studies; Chromatography, High Pressu | 2015 |
Plasma concentrations of three methylated arginines, endogenous nitric oxide synthase inhibitors, in schizophrenic patients undergoing antipsychotic drug treatment.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Arginine; Female; Humans; Male; Middle Aged; N | 2016 |
Increased plasma asymmetric dimethylarginine is associated with cognitive deficits in patients with schizophrenia.
Topics: Adult; Arginine; Biomarkers; Cognition Disorders; Cognitive Dysfunction; Female; Humans; Male; Neuro | 2016 |
Plasma asymmetric dimethylarginine (ADMA) concentrations in patients with first and multiple episode schizophrenia.
Topics: Adult; Arginine; Chromatography, High Pressure Liquid; Humans; Male; Psychiatric Status Rating Scale | 2011 |